Saw Palmetto + Nettle (Combo) for Prostate Health

Research suggests that the combination of saw palmetto (Serenoa repens) and stinging nettle root (Urtica dioica), most commonly studied as the proprietary formulation PRO 160/120 or WS 1541, shows consistent support across a range of study types for improving urinary symptoms associated with benign prostatic hyperplasia (BPH), including nocturia and lower urinary tract symptoms (LUTS). Multiple randomized controlled trials, several supporting reviews, and in vitro and animal model studies collectively point toward anti-proliferative, antioxidant, and anti-inflammatory mechanisms, with one notable clinical trial reporting efficacy comparable to the prescription drug finasteride. Studies indicate that the combination may outperform saw palmetto used alone, as a 2017 review noted that saw palmetto monotherapy has not consistently demonstrated superiority over placebo, while the combination formulation showed more favorable results, and a 2000 meta-analysis found the evidence for nettle root as a standalone agent to be insufficient for firm conclusions. Overall, the body of evidence leans supportive but carries meaningful limitations, including reliance on proprietary extracts that may not generalize to all commercial products, a need for longer and more rigorously designed trials, and variation in study quality across the literature.